SF
CRVO icon

Summit Financial’s CervoMed CRVO Stock Holding History

Summit Financial’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.2K Buy
+18,140
New +$63.9K ﹤0.01% 1572

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Summit Financial's CRVO Position: Q2 2026 in Review

Summit Financial opened a new position in CervoMed (CRVO) in Q2 2026: 18,140 shares worth $56.2K. The stake represents ﹤0.01% of the portfolio and ranks #1572 among its holdings.

37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Summit Financial held 18,140 shares of CervoMed worth $56.2K as of Q2 2026.
  • CervoMed was a new Summit Financial position in Q2 2026.
  • CervoMed made up ﹤0.01% of Summit Financial's portfolio in Q2 2026, its #1572 holding.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.